Asset Details
Do you wish to reserve the book?
Magnetic molecularly imprinted polymer coated with chitosan shell for enhanced controlled drug release
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Magnetic molecularly imprinted polymer coated with chitosan shell for enhanced controlled drug release
Do you wish to request the book?
Magnetic molecularly imprinted polymer coated with chitosan shell for enhanced controlled drug release
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Magnetic molecularly imprinted polymer coated with chitosan shell for enhanced controlled drug release
2026
Overview
A pH-responsive chitosan-coated magnetic molecularly imprinted polymer (MMIP) was developed as a controlled-release drug carrier with enhanced selectivity, loading capacity, and release modulation. The carrier was constructed by synthesizing Fe
3
O
4
@SiO
2
magnetic cores and forming a molecularly imprinted shell using 3-aminopropyltriethoxysilane (APTES) as the functional monomer. Imatinib (IMA
)
, a clinically important tyrosine kinase inhibitor, was used as both the model drug and the template to evaluate the carrier’s performance. To further enhance sustained and pH-responsive release, the MMIP was coated with a biocompatible chitosan (CS) layer after drug loading, yielding a hybrid core–shell nanocomposite (MMIP@CS). Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), vibrating sample magnetometry (VSM), microscopic images and dynamic light scattering (DLS) confirmed its structural integrity, magnetic properties, and well-controlled synthesis process. The system exhibited a high drug loading capacity (65.4%), reflecting strong molecular recognition within the imprinted cavities. The release studies at pH 7.4 and 5.5 demonstrated that the CS coating significantly improved release control over 96 h compared to the uncoated MMIP, enabling sustained and pH-dependent drug delivery. Kinetic modeling indicated that the Korsmeyer–Peppas model best described the release mechanism, suggesting a combined diffusion- and polymer-relaxation-controlled process. In vitro cytotoxicity assays further confirmed that IMA-MMIP@CS exhibited enhanced cytotoxicity against K562 cells while maintaining higher viability in normal PBMCs, highlighting its biocompatibility and therapeutic potential.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
